Related references
Note: Only part of the references are listed.Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity
Valeria Calcaterra et al.
NUTRIENTS (2023)
The links between gut microbiota and obesity and obesity related diseases
Jiafeng Geng et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Effects of Lactobacillus supplementation on glycemic and lipid indices in overweight or obese adults: A systematic review and meta-analysis
Xudong Qiu et al.
CLINICAL NUTRITION (2022)
Epigenetics: A New Frontier in Probiotic Research
Wesley Morovic et al.
TRENDS IN MICROBIOLOGY (2021)
Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs
Francesca Algieri et al.
EUROPEAN JOURNAL OF NUTRITION (2021)
Probiotics and MicroRNA: Their Roles in the Host-Microbe Interactions
Ying Zhao et al.
FRONTIERS IN MICROBIOLOGY (2021)
Lactobacillus Plantarum 299v Changes miRNA Expression in the Intestines of Piglets and Leads to Downregulation of LITAF by Regulating ssc-miR-450a
Qi Wang et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2021)
Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1α Pathway
Tianyu Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Dysregulation of Circulating miR-24-3p in Children with Obesity and Its Predictive Value for Metabolic Syndrome
Bingjin Zhang et al.
OBESITY FACTS (2021)
The impact of probiotic supplementation during pregnancy on DNA methylation of obesity-related genes in mothers and their children
Sanna Vahamiko et al.
EUROPEAN JOURNAL OF NUTRITION (2019)
Circulating microRNAs in human obesity: a systematic review
Alejandra Ortiz-Dosal et al.
BIOMARKERS (2019)
A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements
Bhagavathi Sundaram Sivamaruthi et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome
Zhuo Chen et al.
DNA AND CELL BIOLOGY (2019)
miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19
Asha Acharya et al.
GENES & DEVELOPMENT (2019)
Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial
Leila Khalili et al.
DIABETOLOGY & METABOLIC SYNDROME (2019)
Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer
Zahra Heydari et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
Francesca Cirillo et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post- transcriptional repression of scavenger receptor class Btype I
Kun Ren et al.
ATHEROSCLEROSIS (2018)
Joint EFLM-COLABIOCLI Recommendation for venous blood sampling
Ana-Maria Simundic et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Decreased Serum Level of miR-155 is Associated with Obesity and its Related Metabolic Traits
Roya Mahdavi et al.
CLINICAL LABORATORY (2018)
Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota
Alicia S. Wellman et al.
GASTROENTEROLOGY (2017)
Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes
Yury O. Nunez Lopez et al.
MOLECULAR BIOSYSTEMS (2017)
Shortcuts to a functional adipose tissue: The role of small non-coding RNAs
Bruna B. Brandao et al.
REDOX BIOLOGY (2017)
Obesity-associated Inflammation Induces microRNA-155 Expression in Adipocytes and Adipose Tissue: Outcome on Adipocyte Function
Esma Karkeni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
MicroRNA-26b is upregulated in a double transgenic mouse model of Alzheimer's disease and promotes the expression of amyloid-β by targeting insulin-like growth factor 1
Hong Liu et al.
MOLECULAR MEDICINE REPORTS (2016)
Novel opportunities for next-generation probiotics targeting metabolic syndrome
Patrice D. Cani et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis
Natalya Benderska et al.
INFLAMMATORY BOWEL DISEASES (2015)
MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway
G. Xu et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Inhibition of MicroRNA-24 Expression in Liver Prevents Hepatic Lipid Accumulation and Hyperlipidemia
Raymond Ng et al.
HEPATOLOGY (2014)
MicroRNA 34a Inhibits Beige and Brown Fat Formation in Obesity in Part by Suppressing Adipocyte Fibroblast Growth Factor 21 Signaling and SIRT1 Function
Ting Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
Andreas Schober et al.
NATURE MEDICINE (2014)
Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice
Amandine Everard et al.
MBIO (2014)
MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)
Anja Elaine Sorensen et al.
GENES (2014)
The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
In-Kyu Lee
DIABETES & METABOLISM JOURNAL (2014)
Targeting the Circulating MicroRNA Signature of Obesity
Francisco Jose Ortega et al.
CLINICAL CHEMISTRY (2013)
Modulation of hsa-miR-26b levels following adipokine stimulation
Guangfeng Xu et al.
MOLECULAR BIOLOGY REPORTS (2013)
MicroRNA changes in human arterial endothelial cells with senescence: Relation to apoptosis, eNOS and inflammation
Catarina Rippe et al.
EXPERIMENTAL GERONTOLOGY (2012)
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome
Philippe Ducrotte et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity
M. Carola Zillikens et al.
DIABETES (2009)
Meta-analysis of natural therapies for hyperlipidemia: Plant sterols and stanols versus policosanol
JT Chen et al.
PHARMACOTHERAPY (2005)
Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers
M Naruszewicz et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2002)
Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients
ML Arruzazabala et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2002)
Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent
I Gouni-Berthold et al.
AMERICAN HEART JOURNAL (2002)
Share Paper
